13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 10 managers

Reported value

$115.1M

Holders

10

+0 new · −2 exited

Holders’ est. mark

−$11.9M

Price effect on 6 books still in the name

Largest holder

$92.3M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC1.36M$92.3M−$477.1KCut−$368.1M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main15.3M$15.9M−$11.1MCut−$10.9M
DANSKE BANK A/S73.6K$6.06M−$368.6KCut−$3.16M
Burton Enright Welch3.72K$306.6K−$18.7KCut−$18.7K
Leonteq Securities AG3.35K$276.1K−$7.37KAdded$147.6K
Swiss Life Asset Management Ltd2.7K$222.1K−$13.5KCut−$92.1K
Prestige Wealth Management Group LLC34$2.8KHeld

Who left

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.